Tanja Kirchberger

发表

Trifluoromethylated cyclic-ADP-ribose mimic: synthesis of 8-trifluoromethyl-N(1)-[(5''-O-phosphorylethoxy)methyl]-5'-O-phosphorylinosine-5',5''-cyclic pyrophosphate (8-CF(3)-cIDPRE) and its calcium release activity in T cells.

Zhenjun Yang, A. Guse, T. Kirchberger, 2010, Organic & biomolecular chemistry.

8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist

B. Potter, A. Flügel, F. Odoardi, 2009, The Biochemical journal.

Structure–Activity Relationship of Adenosine 5′-diphosphoribose at the Transient Receptor Potential Melastatin 2 (TRPM2) Channel: Rational Design of Antagonists

B. Potter, A. Guse, Christelle Moreau, 2013, Journal of medicinal chemistry.

NAADP-mediated Ca2+ signaling via type 1 ryanodine receptor in T cells revealed by a synthetic NAADP antagonist

M. Hohenegger, B. Potter, A. Flügel, 2009, Proceedings of the National Academy of Sciences.

Aberrant Cyclization Affords a C-6 Modified Cyclic Adenosine 5′-Diphosphoribose Analogue with Biological Activity in Jurkat T Cells

B. Potter, Mark P Thomas, A. Guse, 2012, Journal of medicinal chemistry.

Cellular effects and metabolic stability of N1‐cyclic inosine diphosphoribose and its derivatives

B. Potter, A. Flügel, C. Cordiglieri, 2006, British journal of pharmacology.

Ins(1,4,5)P3 3-kinase-A overexpression induces cytoskeletal reorganization via a kinase-independent mechanism.

C. Elling, G. Mayr, M. Nalaskowski, 2008, The Biochemical journal.

2'-Deoxyadenosine 5'-diphosphoribose is an endogenous TRPM2 superagonist.

B. Potter, A. Guse, M. Flato, 2017, Nature chemical biology.

Ligand-induced activation of human TRPM2 requires the terminal ribose of ADPR and involves Arg1433 and Tyr1349

B. Potter, Mark P Thomas, A. Guse, 2017, The Biochemical journal.